The Use of Recombinant Factor VIIa on the Therapy of Massive Bleeding after Cesarean Section

Czech version

Authors: P. Uharček; Miloš Mlynček; M. Kellner; E. . Lajtman
Authors‘ workplace: Gynekologicko-pôrodnícka klinika, Fakultná nemocnica Nitra prednosta kliniky doc. MUDr. M. Mlynček, CSc.
Published in: Ceska Gynekol 2007; 72(3): 200-202
Category: Original Article

Overview

Objective:
To present a case report of severe post-partum bleeding after caesarean section and successful treatment using recombinant factor VIIa.

Setting:
Obstetrics and Gynecology Department, Faculty Hospital, Nitra, Slovak Republic.

Case report:
A 29-year old secundigravida presented with major post-partum bleeding after caesarean section due to uterine atony. The patient developed hemorrhagic shock, associated with disseminated intravascular coagulation (DIC). Treatment with uterotonic drugs, prostaglandins and hysterectomy failed to control diffuse bleeding. Recombinant factor VIIa (90 μg/kg intravenous injection) was given as a final attempt to control the bleeding. The response to treatment was rapid, with control of the bleeding and resolution of the coagulopathy.

Conclusion:
This case suggests a potential role of recombination factor VIIa in the treatment of severe post-partum bleeding associated with DIC.

Key words:
recombinant FVIIa; bleeding; postpartum period